IntraBiotics Pharmaceuticals Inc. wanted to clarify that it is not paying $20 million up front to Diversa Corp. Some of the deal's value is in later fees, such as potential milestones. The deal was reported in the Jan. 10, 2000, issue of BioWorld Today.